Cargando…

IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway

Risk stratification using molecular features could potentially help distinguish indolent from aggressive prostate cancer (PCa). Mutations in isocitrate dehydrogenase (IDH) acquire an abnormal enzymatic activity, resulting in the production of 2-hydroxyglutarate and alterations in cellular metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lili, Qi, Mei, Feng, Tingting, Hu, Jing, Wang, Lin, Li, Xinjun, Gao, Wei, Liu, Hui, Jiao, Meng, Wu, Zhen, Bai, Xinnuo, Bie, Yifan, Liu, Long, Han, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767912/ https://www.ncbi.nlm.nih.gov/pubmed/29331887 http://dx.doi.org/10.1016/j.neo.2017.12.001

Ejemplares similares

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
por: Tesileanu, C. Mircea S., et al.
Publicado: (2021)

The prognostic IDH1(R132) mutation is associated with reduced NADP(+)-dependent IDH activity in glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2010)

IDH-1(R132H) mutation status in diffuse glioma patients: implications for classification
por: Wang, Peng-fei, et al.
Publicado: (2016)

Generation and Performance of R132H Mutant IDH1 Rabbit Monoclonal Antibody
por: Rashidian, Juliet, et al.
Publicado: (2017)

IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway
por: Li, Kaishu, et al.
Publicado: (2017)

IDH1-R132 changes vary according to NPM1 and other mutations status in AML
por: Falini, Brunangelo, et al.
Publicado: (2019)

IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma
por: Lu, Jun, et al.
Publicado: (2014)

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
por: Cuyàs, Elisabet, et al.
Publicado: (2015)

IDH1(R132H) in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis
por: Rosiak, Kamila, et al.
Publicado: (2016)

Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer
por: Li, Jieying, et al.
Publicado: (2016)

IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing
por: Lee, Jung Hee, et al.
Publicado: (2017)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Somatic IDH1 variant (p.R132C) in an adult male with Maffucci syndrome
por: Brown, Natasha J., et al.
Publicado: (2021)

Computational study on novel natural compound inhibitor targeting IDH1_R132H
por: Zhou, Baolin, et al.
Publicado: (2022)

R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition
por: Sears, Thomas K., et al.
Publicado: (2022)

LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma
por: Douglas, Christopher, et al.
Publicado: (2023)

IDH1(R132H) Causes Resistance to HDAC Inhibitors by Increasing NANOG in Glioblastoma Cells
por: Kim, Geon-Hee, et al.
Publicado: (2019)

Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
por: Hu, Chujiao, et al.
Publicado: (2022)

Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival
por: Korkolopoulou, P, et al.
Publicado: (2013)

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
por: Pellegatta, Serena, et al.
Publicado: (2015)

ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
por: Cai, Jinquan, et al.
Publicado: (2016)

IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic Tumours
por: Mu, Luyan, et al.
Publicado: (2017)

IDH1(R132H) is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment
por: Tiburcio, Patricia D.B., et al.
Publicado: (2018)

Somatic Mosaicism of IDH1 R132H Predisposes to Anaplastic Astrocytoma: A Case of Two Siblings
por: Lee, Sulgi, et al.
Publicado: (2020)

Mechanisms Underlying Dysregulation of miR-132 in Alzheimer’s Disease
por: Song, Qiaoyun, et al.
Publicado: (2019)

IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
por: Yin, Narui, et al.
Publicado: (2020)

Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures
por: Shmelev, Mikhail E., et al.
Publicado: (2023)

Discovery and Validation of Novel LonP1 and Proteasome Inhibitor in IDH1-R132H Malignant Astrocytoma Models
por: Douglas, Christopher, et al.
Publicado: (2023)

IDH1(R132H) Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia
por: Wang, Xiao-Wei, et al.
Publicado: (2014)

A heterozygous IDH1(R132H/WT) mutation induces genome-wide alterations in DNA methylation
por: Duncan, Christopher G., et al.
Publicado: (2012)

IDH1 R132H predicts sensitivity to Bcl-xL inhibition-mediated programmed cell death
por: Karpel-Massler, Georg, et al.
Publicado: (2017)

IDH1 Expression via the R132H Mutation–Specific Antibody in Adrenocortical Neoplasias—Prognostic Impact in Carcinomas
por: Pennanen, Mirkka, et al.
Publicado: (2020)

IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci’s Syndrome
por: Cheng, Peng, et al.
Publicado: (2021)

Expression of Idh1(R132H) in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis
por: Bardella, Chiara, et al.
Publicado: (2016)

Lack of B and T cell reactivity towards IDH1(R132H) in blood and tumor tissue from LGG patients
por: Weenink, Bas, et al.
Publicado: (2019)

Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain Tumors
por: Yusoff, Abdul Aziz Mohamed, et al.
Publicado: (2016)

Generation of induced neural stem cells with inducible IDH1(R132H) for analysis of glioma development and drug testing
por: Rosiak-Stec, Kamila, et al.
Publicado: (2020)

Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report
por: Lv, Haiyan, et al.
Publicado: (2022)

High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas
por: Wong, Yin Ping, et al.
Publicado: (2022)

Characterization of an IDH1 R132H Rabbit Monoclonal Antibody, MRQ-67, and Its Applications in the Identification of Diffuse Gliomas
por: Copaciu, Raul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l7n54kijbiguj4r11sq9q7eqch